3.4.13.20: beta-Ala-His dipeptidase
This is an abbreviated version!
For detailed information about beta-Ala-His dipeptidase, go to the full flat file.
Word Map on EC 3.4.13.20
-
3.4.13.20
-
carnosine
-
dipeptide
-
nephropathy
-
anserine
-
homocarnosine
-
beta-alanyl-l-histidine
-
l-histidine
-
bestatin
-
n-acetylcarnosine
-
histidine-containing
-
carcinine
-
medicine
-
analysis
-
synthesis
- 3.4.13.20
- carnosine
- dipeptide
- nephropathy
- anserine
- homocarnosine
- beta-alanyl-l-histidine
- l-histidine
- bestatin
-
n-acetylcarnosine
-
histidine-containing
-
carcinine
- medicine
- analysis
- synthesis
Reaction
preferential hydrolysis of the beta-Ala-/-His dipeptide (carnosine), and also anserine, Xaa-/-His dipeptides and other dipeptides including homocarnosine =
Synonyms
carnosinase, carnosinase-1, CN1, CN2, CNDP dipeptidase 2, CNDP1, CNDP2, cytosolic non-specific dipeptidase 2, DmpA, EC 3.4.13.13, EC 3.4.13.3, EC 3.4.3.3, serum carnosinase, tissue carnosinase
ECTree
Advanced search results
Organism
Organism on EC 3.4.13.20 - beta-Ala-His dipeptidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
diabetic patients with the CDDP1 Mannheim variant are less susceptible for nephropathy
-
-
enzyme activities in patients with idiopathic epilepsy and motor neurone disease are similar to the control group. Reduced serum carnosinase activity is observed in patients with multiple sclerosis and patients following a cerebrovascular accident
-
-
little or no activity in children below 10 months in age thereafter, the average concentration increases gradually to reach the adult range at the age 13-15
-
-